A "post-polio" syndrome characterized by new neuromuscular symptoms, including muscle weakness, may develop years after recovery from acute paralytic poliomyelitis. We studied 27 patients (mean age, 50.6 years) in whom new muscle weakness developed a mean of 28.8 years after recovery from acute polio. We reevaluated these patients during a mean follow-up period of 8.2 years (range, 4.5 to 20) after they were originally studied at the National Institutes of Health. The total mean follow-up period after the onset of new weakness was 12.2 years (range, 6 to 29). The patients were assessed with quantitative muscle testing, muscle biopsy, electromyography, and virologic and immunologic examination of the cerebrospinal fluid. Muscle strength had declined in all patients. The rate of decline averaged 1 percent per year. The decrease was irregular, with subjective plateau periods that ranged from 1 to 10 years. None of the patients had amyotrophic lateral sclerosis. Oligoclonal bands (IgG) were found in the cerebrospinal fluid of 7 of 13 patients studied, but no specific elevation of antibodies to poliovirus was observed in the cerebrospinal fluid. The newly affected muscles that were evaluated longitudinally with follow-up muscle biopsies and electromyography showed signs of chronic and new denervation. Groups of atrophic muscle fibers (group atrophy) and "neurogenic jitter" were not present. New post-polio muscle weakness is not a life-threatening form of motor-neuron deterioration. It appears that this weakness is not due to a loss of whole motor neurons, as in amyotrophic lateral sclerosis, but that it is due to a dysfunction of the surviving motor neurons that causes a slow disintegration of the terminals of individual nerve axons.
This article has been cited by other articles:
Vasconcelos, O. M., Prokhorenko, O. A., Salajegheh, M. K., Kelley, K. F., Livornese, K., Olsen, C. H., Vo, A. H., Dalakas, M. C., Halstead, L. S., Jabbari, B., Campbell, W. W.
(2007). Modafinil for treatment of fatigue in post-polio syndrome: A randomized controlled trial. Neurology
68: 1680-1686
[Abstract][Full Text]
Salajegheh, M., Bryan, W. W., Dalakas, M. C.
(2006). The challenge of diagnosing ALS in patients with prior poliomyelitis.. Neurology
67: 1078-1079
[Abstract][Full Text]
Hebl, J. R., Horlocker, T. T., Schroeder, D. R.
(2006). Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders.. Anesth. Analg.
103: 223-228
[Abstract][Full Text]
Howard, R. S
(2005). Poliomyelitis and the postpolio syndrome. BMJ
330: 1314-1318
[Full Text]
Kim, J. W., Rizzo, J. F., Lessell, S.
(2005). Delayed Visual Decline in Patients With "Stable" Optic Neuropathy. Arch Ophthalmol
123: 785-788
[Abstract][Full Text]
Rekand, T, Korv, J, Farbu, E, Roose, M, Gilhus, N E, Langeland, N, Aarli, J A
(2003). Long term outcome after poliomyelitis in different health and social conditions. J. Epidemiol. Community Health
57: 368-372
[Abstract][Full Text]
Schott, G. D.
(2001). Delayed onset and resolution of pain: Some observations and implications. Brain
124: 1067-1076
[Abstract][Full Text]
Jubelt, B., Agre, J. C.
(2000). Characteristics and Management of Postpolio Syndrome. JAMA
284: 412-414
[Full Text]
Dalakas, M. C.
(1999). Why drugs fail in postpolio syndrome. Neurology
53: 1166-1166
[Full Text]
Trojan, D. A., Cashman, N. R.
(1995). Fibromyalgia Is Common in a Postpoliomyelitis Clinic. Arch Neurol
52: 620-624
[Abstract]
Thornton, A. F., Zimberg, S. H., Greenberg, H. S., Sullivan, M. J.
(1991). Protracted Lhermitte's Sign Following Head and Neck Irradiation. Arch Otolaryngol Head Neck Surg
117: 1300-1303
[Abstract]
Jones, D. R., Speier, J., Canine, K., Owen, R., Stull, G. A.
(1989). Cardiorespiratory Responses to Aerobic Training by Patients With Postpoliomyelitis Sequelae. JAMA
261: 3255-3258
[Abstract]
Yarnell, S. K.
(1989). Poliomyelitis: The Battle Continues. JAMA
261: 3294-3295
[Abstract]
Ginsberg, A. H., Gale, M. J. Jr, Rose, L. M., Clark, E. A.
(1989). T-Cell Alterations in Late Postpoliomyelitis. Arch Neurol
46: 497-501
[Abstract]
Lange, D. J., Smith, T., Lovelace, R. E.
(1989). Postpolio Muscular Atrophy: Diagnostic Utility of Macroelectromyography. Arch Neurol
46: 502-506
[Abstract]
Klingman, J., Chui, H., Corgiat, M., Perry, J.
(1988). Functional Recovery: A Major Risk Factor for the Development of Postpoliomyelitis Muscular Atrophy. Arch Neurol
45: 645-647
[Abstract]
Pezeshkpour, G. H., Dalakas, M. C.
(1988). Long-term Changes in the Spinal Cords of Patients With Old Poliomyelitis: Signs of Continuous Disease Activity. Arch Neurol
45: 505-508
[Abstract]
Mitsumoto, H., Hanson, M. R., Chad, D. A.
(1988). Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials. Arch Neurol
45: 189-202
[Abstract]
Elias, S. B.
(1987). Oligodendrocyte Development and the Natural History of Multiple Sclerosis: A New Hypothesis for the Pathogenesis of the Disease. Arch Neurol
44: 1294-1299
[Abstract]
Summers, G., Cochrane, G.
(1987). Review article : The late effects of poliomyelitis: aetiology and rehabilitation. Clin Rehabil
1: 325-334
[Abstract]
Dalakas, M. C., Aksamit, A. J., Madden, D. L., Sever, J. L.
(1986). Administration of Recombinant Human Leukocyte {alpha}2-Interferon in Patients With Amyotrophic Lateral Sclerosis. Arch Neurol
43: 933-935
[Abstract]
Previous
